Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ATAI NASDAQ:CMPS OTCMKTS:CURLF NYSE:IIPR NYSEARCA:MSOS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeATAIAtai Beckley$4.04-4.7%$3.91$1.39▼$6.75$1.56B1.598.03 million shs2.88 million shsCMPSCompass Pathways$10.62-3.1%$7.16$2.25▼$11.28$1.41B2.396.48 million shs4.48 million shsCURLFCuraleaf$3.94$2.74$0.72▼$5.05$2.75B1.581.69 million shs620,977 shsIIPRInnovative Industrial Properties$54.84-0.2%$53.23$44.58▼$61.40$1.58B1.43398,658 shs220,559 shsMSOSAdvisorShares Pure US Cannabis ETF$4.84-0.4%$4.16$2.06▼$7.25$1.01B1.357.69 million shs4.09 million shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceATAIAtai Beckley-4.72%+0.75%+4.94%+13.17%+182.52%CMPSCompass Pathways-3.10%+13.10%+84.70%+82.79%+175.13%CURLFCuraleaf0.00%+0.41%+62.88%+62.81%+346.71%IIPRInnovative Industrial Properties-0.26%-3.37%+7.12%+19.23%-0.98%MSOSAdvisorShares Pure US Cannabis ETF-0.41%-7.63%+24.74%+22.22%+80.60%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeATAIAtai Beckley$4.04-4.7%$3.91$1.39▼$6.75$1.56B1.598.03 million shs2.88 million shsCMPSCompass Pathways$10.62-3.1%$7.16$2.25▼$11.28$1.41B2.396.48 million shs4.48 million shsCURLFCuraleaf$3.94$2.74$0.72▼$5.05$2.75B1.581.69 million shs620,977 shsIIPRInnovative Industrial Properties$54.84-0.2%$53.23$44.58▼$61.40$1.58B1.43398,658 shs220,559 shsMSOSAdvisorShares Pure US Cannabis ETF$4.84-0.4%$4.16$2.06▼$7.25$1.01B1.357.69 million shs4.09 million shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceATAIAtai Beckley-4.72%+0.75%+4.94%+13.17%+182.52%CMPSCompass Pathways-3.10%+13.10%+84.70%+82.79%+175.13%CURLFCuraleaf0.00%+0.41%+62.88%+62.81%+346.71%IIPRInnovative Industrial Properties-0.26%-3.37%+7.12%+19.23%-0.98%MSOSAdvisorShares Pure US Cannabis ETF-0.41%-7.63%+24.74%+22.22%+80.60%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceATAIAtai Beckley 2.91Moderate Buy$14.63262.00% UpsideCMPSCompass Pathways 2.91Moderate Buy$20.6494.32% UpsideCURLFCuraleaf 3.75Strong BuyN/AN/AIIPRInnovative Industrial Properties 1.60Reduce$45.00-17.94% DownsideMSOSAdvisorShares Pure US Cannabis ETF 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest CMPS, ATAI, MSOS, CURLF, and IIPR Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/14/2026CMPSCompass Pathways Morgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$16.00 ➝ $17.005/14/2026CMPSCompass Pathways Royal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$21.00 ➝ $22.005/13/2026CMPSCompass Pathways BTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$14.005/8/2026IIPRInnovative Industrial Properties Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold (C-) ➝ Sell (D+)5/7/2026CMPSCompass Pathways UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$18.005/5/2026CMPSCompass Pathways Jefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong-Buy5/5/2026CURLFCuraleaf Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Strong-Buy5/5/2026IIPRInnovative Industrial Properties Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold5/3/2026CMPSCompass Pathways Jefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$18.004/28/2026CMPSCompass Pathways HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$70.004/24/2026CMPSCompass Pathways UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$17.00(Data available from 5/15/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookATAIAtai Beckley$4.09M363.67N/AN/A$0.69 per share5.86CMPSCompass PathwaysN/AN/AN/AN/A($0.55) per shareN/ACURLFCuraleaf$1.27B2.17$0.05 per share71.89$1.18 per share3.34IIPRInnovative Industrial Properties$265.95M5.93$6.92 per share7.92$62.08 per share0.88MSOSAdvisorShares Pure US Cannabis ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateATAIAtai Beckley-$660.05M-$2.30N/AN/AN/A-19,019.44%-89.79%-63.58%N/ACMPSCompass Pathways-$287.86M-$3.15N/AN/AN/AN/A-74.98%-14.54%7/30/2026 (Estimated)CURLFCuraleaf-$231.07M-$0.13N/AN/AN/A-7.76%-8.11%-2.36%N/AIIPRInnovative Industrial Properties$118.25M$3.9114.027.38N/A45.58%6.62%5.10%N/AMSOSAdvisorShares Pure US Cannabis ETFN/AN/A12.20N/AN/AN/AN/AN/AN/ALatest CMPS, ATAI, MSOS, CURLF, and IIPR EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/13/2026Q1 2026CMPSCompass Pathways-$0.45-$0.30+$0.15-$0.30N/AN/A5/12/2026Q4 2025ATAIAtai Beckley-$0.11-$0.08+$0.03-$0.08$0.22 million$0.95 million5/5/2026Q1 2026CURLFCuraleaf-$0.08$0.09+$0.17$0.09$316.62 million$324.23 million5/4/2026Q1 2026IIPRInnovative Industrial Properties$1.07$1.02-$0.05$1.02$65.65 million$69.00 million3/24/2026Q4 2025CMPSCompass Pathways-$0.41-$1.00-$0.59-$1.00N/AN/A3/7/2026Q4 2025ATAIAtai Beckley-$0.12-$0.05+$0.07-$1.73$1.50 million$1.07 million2/26/2026Q4 2025CURLFCuraleaf-$0.08-$0.05+$0.03-$0.08$328.70 million$333.07 million2/23/2026Q4 2025IIPRInnovative Industrial Properties$1.71$1.88+$0.17$1.06$66.16 million$66.66 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthATAIAtai BeckleyN/AN/AN/AN/AN/ACMPSCompass PathwaysN/AN/AN/AN/AN/ACURLFCuraleafN/AN/AN/AN/AN/AIIPRInnovative Industrial Properties$7.6013.86%+11.20%194.37%4 YearsMSOSAdvisorShares Pure US Cannabis ETF$0.071.45%N/AN/AN/ALatest CMPS, ATAI, MSOS, CURLF, and IIPR DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date3/13/2026IIPRInnovative Industrial Propertiesquarterly$1.9015.16%3/31/20263/31/20264/15/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioATAIAtai Beckley0.027.907.90CMPSCompass Pathways0.550.770.77CURLFCuraleaf1.051.560.74IIPRInnovative Industrial Properties0.206.066.06MSOSAdvisorShares Pure US Cannabis ETFN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipATAIAtai Beckley28.41%CMPSCompass Pathways46.19%CURLFCuraleaf0.03%IIPRInnovative Industrial Properties70.58%MSOSAdvisorShares Pure US Cannabis ETFN/AInsider OwnershipCompanyInsider OwnershipATAIAtai Beckley26.80%CMPSCompass Pathways2.82%CURLFCuraleafN/AIIPRInnovative Industrial Properties2.00%MSOSAdvisorShares Pure US Cannabis ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableATAIAtai Beckley80368.17 million268.58 millionOptionableCMPSCompass Pathways120128.92 million125.29 millionOptionableCURLFCuraleaf5,554698.20 millionN/ANot OptionableIIPRInnovative Industrial Properties2028.77 million28.20 millionOptionableMSOSAdvisorShares Pure US Cannabis ETFN/A208.22 millionN/ANot OptionableCMPS, ATAI, MSOS, CURLF, and IIPR HeadlinesRecent News About These CompaniesUS Reclassifies Weed: Can Cannabis ETFs Give Your Portfolio a New High?May 14 at 2:10 PM | zacks.com3 Top Picks For Marijuana Stocks Investors To See Profits In 2026May 11, 2026 | marijuanastocks.comMCannabis Rescheduling Could Unlock the Biggest MSO Rally Since 2021May 6, 2026 | 247wallst.comTrump’s Rescheduling of Marijuana Is a Spark for Top Marijuana ETFs (MSOS)...May 3, 2026 | marketbeat.comAdvisorShares Pure US Cannabis ETF : MSOSMay 1, 2026 | 247wallst.comCannabis ETFs: Regulatory Momentum Returns FocusApril 30, 2026 | etftrends.comEFocus: Companies with cannabis-based drugs eye IPOs, private funding boost after US reclassificationApril 30, 2026 | reuters.comTop U.S. Marijuana Stocks to Watch in April 2026 as the Sector Heats UpApril 28, 2026 | marijuanastocks.comM4 Best-Performing ETF Areas of Last WeekApril 28, 2026 | zacks.comMedical Marijuana Reclassified as Less Dangerous DrugApril 23, 2026 | barrons.comThe Last Cannabis ETFs Worth Your Money: Why Most Failed and 3 Are Still TradingApril 23, 2026 | 247wallst.comMSOS: Trump's Green Light - Why Cannabis Stocks Are Surging On Rescheduling News (Rating Upgrade)April 22, 2026 | seekingalpha.comThis 4/20, Wall Street Is Betting on More Than Marijuana (MSOS)...April 20, 2026 | marketbeat.comMSOS: The Question Is Not If, But 'When' The Rescheduling Will OccurMarch 12, 2026 | seekingalpha.comThe One IRS Rule Keeping Cannabis Stocks Down Despite Record Cash FlowMarch 12, 2026 | 247wallst.com3 Reasons Why These 3 Cannabis Stocks Could Have a Magnificent 2026January 27, 2026 | 247wallst.comIt Was Not Great NewsJanuary 23, 2026 | newcannabisventures.comNTrump's Cannabis Rescheduling Order Could Finally Kill A Crushing Tax Rule And Transform US Weed Stocks, Says ExpertJanuary 19, 2026 | benzinga.comMSOS ETF Drops 26% in One Month as Federal Cannabis Policy StallsJanuary 18, 2026 | 247wallst.comMSOS ETF Drops 26% in One Month as Federal Cannabis Policy StallsJanuary 18, 2026 | 247wallst.comWant to buy some of the best marijuana stocks for 2026? Consider this ETF.January 13, 2026 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesThe Real SpaceX Play: 5 Chip Stocks Powering the IPO Before It LaunchesBy Bridget Bennett | May 4, 2026This 4/20, Wall Street Is Betting on More Than MarijuanaBy Jeffrey Neal Johnson | April 20, 2026The Cannabis Sector's Billion-Dollar Tax CutBy Jeffrey Neal Johnson | April 23, 2026These 3 Psychedelic Stocks Activated After Trump's Executive OrderBy Nathan Reiff | April 27, 2026Trump’s Rescheduling of Marijuana Is a Spark for Top Marijuana ETFsBy Jessica Mitacek | May 3, 2026CMPS, ATAI, MSOS, CURLF, and IIPR Company DescriptionsAtai Beckley NASDAQ:ATAI$4.04 -0.20 (-4.72%) Closing price 05/14/2026 04:00 PM EasternExtended Trading$4.08 +0.04 (+0.99%) As of 05:56 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Atai Beckley N.V., a clinical-stage biopharmaceutical company, develops and invests in various therapeutics to treat depression, anxiety, addiction, and other mental health disorders. Its product candidates include COMP360, a proprietary psilocybin which is in Phase 3 program; BPL-003, an intranasal formulation that is in Phase 2a and 2b clinical studies; TRD; VLS-01, an transmucosal film in Phase 1b clinical studies; and ELE-101, a serotonergic psychedelic that is in Phase 1/2a study, for the treatment of treatment resistant depression. The company also develop IBX-210, an intravenous formulation of ibogaine, and DMX-1002, an oral formulation of ibogaine indicated for the treatment of opioid use disorder; EMP-01, an oral formulation of an R-MDMA derivative being developed for the treatment of post-traumatic stress disorder; and EGX-A and EGX-B, psychedelic-like with novel, non-tryptamine structures with differentiated 5-HT receptor pharmacology. In addition, it offers RL-007, an orally bioavailable compound, which is a pro-cognitive neuromodulator for cognitive impairment associated with schizophrenia; and GRX-917, a deuterated etifoxine for the treatment of generalize anxiety disorder. Further, the company develops PCN-101, a subcutaneous formulation of R-ketamine, as a therapy for psychiatric indications initially focused on TRD; KUR-101, a formulation of deuterated mitragynine for the treatment of OUD; and RLS-01, indicated for treatment resistant depression. Atai Beckley N.V. was founded in 2018 and is headquartered in Berlin, Germany with offices in New York and London.Compass Pathways NASDAQ:CMPS$10.62 -0.34 (-3.10%) Closing price 05/14/2026 04:00 PM EasternExtended Trading$10.45 -0.17 (-1.60%) As of 05:41 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Compass Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that is in Phase III clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to Compass Pathways plc in August 2020. Compass Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.Curaleaf OTCMKTS:CURLF$3.94 0.00 (0.00%) As of 05/14/2026 03:59 PM EasternCuraleaf Holdings, Inc. operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles. It also provides hemp-based products and cannabinoids, such as cannabidiol and cannabigerol. In addition, the company engages in the cultivation, production, and sale of cannabis products through retail and wholesale channels. The company is headquartered in New York, New York.Innovative Industrial Properties NYSE:IIPR$54.84 -0.09 (-0.17%) Closing price 05/14/2026 03:59 PM EasternExtended Trading$54.97 +0.14 (+0.25%) As of 05:59 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Innovative Industrial Properties, Inc. is a self-advised Maryland corporation focused on the acquisition, ownership and management of specialized properties leased to experienced, state-licensed operators for their regulated cannabis facilities. Innovative Industrial Properties, Inc. has elected to be taxed as a real estate investment trust, commencing with the year ended December 31, 2017.AdvisorShares Pure US Cannabis ETF NYSEARCA:MSOS$4.84 -0.02 (-0.41%) As of 05/14/2026 04:10 PM EasternThe AdvisorShares Pure US Cannabis ETF (MSOS) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed narrow portfolio of US stocks or swap contracts related to the domestic cannabis and hemp industry. MSOS was launched on Sep 1, 2020 and is managed by AdvisorShares. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas YETI Rallies After Earnings Beat and Raised Outlook Cisco’s Vertical Rally May Still Be in the Early Innings Dividend Growth or High Yield: The Income Investor's Bet Nebius Upside Expands as AI Feedback Loop Intensifies Oklo Stock Could Be Ready for Another Massive Run Amazon vs. Alibaba: One Is Clearly The Better Value Play right Now Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell Qualcomm Stock Doubles: New Era? Or Another False Start? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
